Delisting risk
Quoin Pharmaceuticals (ADR) (QNRX)
Developing topical therapies for rare genetic skin diseases.
$6.57
Pre-market−0.24 (−3.50%)
At close$6.81(+4.53%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions20 holders · as of Mar 31, 2026 | 49.16% | 2.37M ADS | |
| Insiders6 holders · as of Sep 1, 2026 | 5.81% | 279.8K ADS | |
| Otherremainder | 45.03% | 2.17M ADS |
4.82M ADS (1 ADS = 15 ordinary shares) as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (4.82M in the company's Sep 3, 2026 report, 2.01M elsewhere); stakes use the report.
This company has 2 share classes; every stake here is a share of the whole company.
Institutions13F, as of Mar 31, 2026
20 holders · 1.18M shares · 5 new positions · 12 increased · 4 reduced · 3 closed
| Holder | Shares | % of company | Chg q/q | Filed |
|---|---|---|---|---|
| Ikarian Capital, LLC | 211.5K | 4.39% | 0 | May 15, 2026 |
| Dauntless Investment Group, LLC | 196.6K | 4.08% | +196.6Knew | May 14, 2026 |
| Summittx Capital, L.P. | 100.3K | 2.08% | +35.5K | May 15, 2026 |
| Velan Capital Investment Management LP | 84.8K | 1.76% | +84.8Knew | May 15, 2026 |
| Woodline Partners LP | 79.6K | 1.65% | 0 | May 15, 2026 |
| Millennium Management LLC | 76.2K | 1.58% | +1.4K | May 15, 2026 |
| Abrdn PLC | 75.0K | 1.56% | 0 | Apr 29, 2026 |
| Soleus Capital Management, L.P. | 72.7K | 1.51% | +47.7K | May 14, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Ikarian Capital, LLC | 12.60% | 211.5K | 13G | Feb 6, 2026 ↗ |
| Stonepine Capital Management, LLC | 9.99% | 13G | May 15, 2026 ↗ | |
| Armistice Capital, LLC | 9.99% | 934.3K | 13G | Feb 14, 2025 ↗ |
| Resolute Capital Asset Partners LLC | 8.50% | 50.0K | 13G | Dec 11, 2025 ↗ |
| Integrated Core Strategies (US) LLC | 5.50% | 13G | Jun 2, 2026 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 31, 2026 | Michael Myersdirector, officer: Chief Executive Officer | Purchase · 2 lots | 30,735 | $5.29 | 47,958 |
| Aug 31, 2026 | Denise P. Carterdirector, officer: Chief Operating Officer | Purchase · 2 lots | 30,735 | $5.29 | 47,954 |
| Aug 31, 2026 | Anthony James Culverwelldirector | Purchase · 2 lots | 9,219 | $5.29 | 43,437 |
| Aug 31, 2026 | Sally Bridget Lawlorofficer: Chief Financial Officer | Purchase · 2 lots | 15,366 | $5.29 | 15,806 |
| Oct 14, 2025 | Dennis Langerdirector | Purchase · 5 lots | 75,760 | $10.53 | 75,761 |
CongressHouse and Senate disclosures
Not reported.